Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 14;6(42):27755-27762.
doi: 10.1021/acsomega.1c03135. eCollection 2021 Oct 26.

Paper-Based Potentiometric Device for Rapid and Selective Determination of Salicylhydroxamate as a Urinary Struvite Stone Inhibitor

Affiliations

Paper-Based Potentiometric Device for Rapid and Selective Determination of Salicylhydroxamate as a Urinary Struvite Stone Inhibitor

Hisham S M Abd-Rabboh et al. ACS Omega. .

Abstract

Novel paper-based potentiometric platforms for rapid, cost-effective, and simple determination of the salicylhydroxamic acid (SHAM) drug are presented. Both the SHAM sensor and the reference Ag/AgCl electrode were integrated together on the miniaturized paper platforms. The ion-sensing membrane for the presented sensor is based on the use of SnIV-tetraphenylporphyrin (SnIVTPP) as a charged carrier within a plasticized poly(vinyl chloride) (PVC) matrix. Multiwalled carbon nanotubes (MWCNTs) were used as an ion-to-electron transducer. The resulting sensor revealed a rapid and stable response with a Nernstian slope of -59.3 ± 0.7 mV/decade over the linear range of 1.0 × 10-6 to 1.0 × 10-3 M and a detection limit of 0.7 μM. All measurements were carried out in 30 mM phosphate-buffered solution (PBS) at pH 7.2. Intra- and interday precision were measured and found to be 1.7%. The relative standard deviation (RSD%) ( = 5) was calculated as 2.43% after utilizing five different electrodes (n = 5). The selectivity behavior of the prepared electrodes in the absence and presence of ionic additives was evaluated. The selectivity pattern showed a non-Hofmeister selectivity pattern in the existence of anionic additives with enhanced potentiometric selectivity for SHAM over different lipophilic anions (e.g., ClO4 -, SCN-, and I-). The presented device was successfully applied for SHAM determination in pharmaceutical preparations. This paper-based analytical device can be potentially manufactured at large scales and provides a portable, rapid, disposable, and cost-effective analytical tool for measuring the SHAM drug.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Schematic representation of the paper-based cell.
Figure 2
Figure 2
Calibration plot of SHAM paper-based sensors in 30 mM PBS, pH 7.2.
Figure 3
Figure 3
Schematic representation of the response mechanism of the presented sensor.
Figure 4
Figure 4
Day-to-day performance characteristics of sensor II.

References

    1. Indiani C.; Santoni E.; Becucci M.; Boffi A.; K Fukuyama K.; Smulevich G. New Insight into the Peroxidase–Hydroxamic Acid Interaction Revealed by the Combination of Spectroscopic and Crystallographic Studies. Biochemistry 2003, 42, 14066–14074. 10.1021/bi035290l. - DOI - PubMed
    1. O’Brien E. C.; Farkas E.; Gil M. J.; Fitzgerald D.; Castineras A.; K B Nolan K. B. Metal complexes of salicylhydroxamic acid (H2Sha), anthranilic hydroxamic acid and benzohydroxamic acid. Crystal and molecular structure of [Cu(phen)2(Cl)]Cl·H2Sha, a model for a peroxidase-inhibitor complex. J. Inorg. Biochem. 2000, 79, 47–51. 10.1016/S0162-0134(99)00245-7. - DOI - PubMed
    1. Arnold M.; Brown D. A.; Deeg O.; Errington W.; Herlihy K.; Kemp T. J.; Nimir H.; Werner R.; Haase W. Hydroxamate-Bridged Dinuclear Nickel Complexes as Models for Urease Inhibition. Inorg. Chem. 1998, 37, 2920–2925. 10.1021/ic9711628. - DOI
    1. Muri E. M. F.; Nieto M. J.; Sindelar R. D.; Williamson J. S. Hydroxamic Acids as Pharmacological Agents. Curr. Med. Chem. 2002, 9, 1631–1653. 10.2174/0929867023369402. - DOI - PubMed
    1. Steward W. P.; Thomas A. L. Marimastat: the clinical development of a matrix metalloproteinase inhibitor. Expert Opin. Invest. Drugs 2000, 9, 2913–2922. 10.1517/13543784.9.12.2913. - DOI - PubMed